# Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection

> **NCT01606163** · PHASE1 · COMPLETED · sponsor: **Green Cross Corporation** · enrollment: 36 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** GC1102
- **OTHER:** JW normal saline

## Key facts

- **NCT ID:** NCT01606163
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-06
- **Final completion:** 2013-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01606163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01606163, "Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01606163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*